Overview

Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation

Status:
Completed
Trial end date:
2015-06-09
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of naldemedine in the treatment of opioid-induced constipation (OIC) in adults with non-malignant chronic pain who are not using laxatives.
Phase:
Phase 3
Details
Lead Sponsor:
Shionogi
Treatments:
Analgesics, Opioid